The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients

References

• Boskey AL, Imbert L. Bone quality changes associated with aging and disease: a review. Ann N Y Acad Sci. 2017;1410(1):93–106.29265417
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.23245607
   PubMed Web of Science ®Google Scholar
• Schnake KJ, Rappert D, Storzer B, Schreyer S, Hilber F, Mehren C. [Lumbar fusion-Indications and techniques]. Der Orthopade. 2019;48(1):50–58. German.30552449
   PubMed Web of Science ®Google Scholar
• Lubelski D, Choma TJ, Steinmetz MP, Harrop JS, Mroz TE. Perioperative medical management of spine surgery patients with osteoporosis. Neurosurgery. 2015;77(Suppl 4):S92–97.26378362
   PubMed Web of Science ®Google Scholar
• Uei H, Tokuhashi Y, Maseda M, et al. Exploratory analysis of predictors of revision surgery for proximal junctional kyphosis or additional postoperative vertebral fracture following adult spinal deformity surgery in elderly patients: a retrospective cohort study. J Orthop Surg Res. 2018;13(1):252.30314520
   PubMed Web of Science ®Google Scholar
• Zou D, Jiang S, Zhou S, et al. Prevalence of osteoporosis in patients undergoing lumbar fusion for lumbar degenerative diseases: a combination of DXA and Hounsfield units. Spine. 2020;45(7):E406–e410.31725127
   PubMed Web of Science ®Google Scholar
• Langdahl BL. Overview of treatment approaches to osteoporosis. Br J Pharmacol. 2021;178(9):1891–1906.32060897
   PubMed Web of Science ®Google Scholar
• Russell RG. Bisphosphonates: from bench to bedside. Ann N Y Acad Sci. 2006;1068:367–401.16831938
   PubMed Web of Science ®Google Scholar
• Coxon FP, Helfrich MH, Van’t Hof R, et al. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Mineral Res. 2000;15(8):1467–1476.
   PubMed Web of Science ®Google Scholar
• Ding Q, Chen J, Fan J, Li Q, Yin G, Yu L. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients. Eur Spine J. 2017;26(11):2969–2977.28865035
   PubMed Web of Science ®Google Scholar
• Tu CW, Huang KF, Hsu HT, Li HY, Yang SS, Chen YC. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis. J Surg Res. 2014;192(1):112–116.24948545
   PubMed Web of Science ®Google Scholar
• Yasen M, Li X, Jiang L, Yuan W, Che W, Dong J. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis. J Orthop Res. 2015;33(9):1297–1304.26011820
   PubMed Web of Science ®Google Scholar
• Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016;27(8):2395–2410.26902094
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kashii M, Matsuo Y, et al. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis. Spine J. 2015;15(2):298–306.25110274
   PubMed Web of Science ®Google Scholar
• Yishake M, Yasen M, Jiang L, et al. Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia. J Orthop Res. 2018;36(3):937–944.28796280
   PubMed Web of Science ®Google Scholar
• Qaseem A, Forciea MA, McLean RM, Denberg TD. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med. 2017;166(11):818–839.28492856
   PubMed Web of Science ®Google Scholar
• Resnick DK, Watters WC 3rd, Sharan A, et al. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 9: lumbar fusion for stenosis with spondylolisthesis. J Neurosurg Spine. 2014;21(1):54–61.24980586
   PubMed Web of Science ®Google Scholar
• Brantigan JW, Steffee AD, Lewis ML, Quinn LM, Persenaire JM. Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial. Spine. 2000;25(11):1437–1446.10828927
   PubMed Web of Science ®Google Scholar
• Seki S, Hirano N, Kawaguchi Y, et al. Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis. Eur Spine J. 2017;26(8):2121–2127.28116510
   PubMed Web of Science ®Google Scholar
• Ohtori S, Inoue G, Orita S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine. 2013;38(8):E487–492.23354115
   PubMed Web of Science ®Google Scholar
• Huang RC, Khan SN, Sandhu HS, et al. Alendronate inhibits spine fusion in a rat model. Spine. 2005;30(22):2516–2522.16284589
   PubMed Web of Science ®Google Scholar
• Li C, Wang HR, Li XL, Zhou XG, Dong J. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir. 2012;154(4):731–738.22297398
   PubMed Web of Science ®Google Scholar
• Kendler DL, Marin F, Zerbini CAF, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391(10117):230–240.29129436
   PubMed Web of Science ®Google Scholar
• Wang C. Efficacy and safety of zoledronic acid for treatment of postmenopausal osteoporosis: a meta-analysis of randomized controlled trials. Am J Ther. 2017;24(5):e544–e552.26938765
   PubMed Web of Science ®Google Scholar
• Ebata S, Takahashi J, Hasegawa T, et al. Role of weekly teriparatide administration in osseous union enhancement within six months after posterior or transforaminal lumbar interbody fusion for osteoporosis-associated lumbar degenerative disorders: a multicenter, prospective randomized study. J Bone Joint Surg Am. 2017;99(5):365–372.28244906
   PubMed Web of Science ®Google Scholar
• Anderson JT, Tye EY, Haas AR, et al. Multilevel lumbar fusion is a risk factor for lower return to work rates among workers’ compensation subjects with degenerative disc disease. J Surg Orthop Adv. 2018;27(3):209–218.30489246
   PubMedGoogle Scholar
• Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420.21184054
   PubMed Web of Science ®Google Scholar
• Eastell R, Mitlak BH, Wang Y, Hu M, Fitzpatrick LA, Black DM. Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporos Int. 2019;30(3):667–673.30635696
   PubMed Web of Science ®Google Scholar
• Liang BC, Shi ZY, Wang B, et al. Intravenous zoledronic acid 5 mg on bone turnover markers and bone mineral density in East China subjects with newly diagnosed osteoporosis: a 24-month clinical study. Orthop Surg. 2017;9(1):103–109.28276638
   PubMed Web of Science ®Google Scholar
• Rubin MR, Cosman F, Lindsay R, Bilezikian JP. The anabolic effects of parathyroid hormone. Osteoporos Int. 2002;13(4):267–277.12030541
   PubMed Web of Science ®Google Scholar
• Gopalaswamy V, Dhibar DP, Gupta V, et al. Anabolic bone window with weekly teriparatide therapy in postmenopausal osteoporosis: a pilot study. Endocrine Pract. 2017;23(6):657–661.
   Web of Science ®Google Scholar
• McClung MR, San Martin J, Miller PD, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005;165(15):1762–1768.16087825
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Goulis DG, Polyzos SA, et al. Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. Int J Clin Pract. 2008;62(6):919–924.18422590
   PubMed Web of Science ®Google Scholar
• O’Loughlin PF, Cunningham ME, Bukata SV, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine. 2009;34(2):121–130.19112335
   PubMed Web of Science ®Google Scholar
• Yagi M, Ohne H, Konomi T, et al. Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity. Osteoporos Int. 2016;27(12):3495–3502.27341809
   PubMed Web of Science ®Google Scholar
• Chen CM, Lin PY, Chen YC, et al. Effects of teriparatide on lung function and pain relief in women with multiple osteoporotic vertebral compression fractures. Surg Neurol Int. 2014;5(Suppl 7):S339–342.25289156
   PubMedGoogle Scholar
• Fatima N, Massaad E, Hadzipasic M, Shankar GM, Shin JH. Assessment of the efficacy of teriparatide treatment for osteoporosis on lumbar fusion surgery outcomes: a systematic review and meta-analysis. Neurosurg Rev. 2020.
   Web of Science ®Google Scholar
• Kawabata A, Yoshii T, Hirai T, et al. Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study. BMC Musculoskelet Disord. 2020;21(1):420.32611386
   PubMed Web of Science ®Google Scholar
• Cheng ML, Gupta V. Teriparatide - Indications beyond osteoporosis. Indian J Endocrinol Metab. 2012;16(3):343–348.22629497
   PubMedGoogle Scholar
• Ohtori S, Inoue G, Orita S, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine. 2012;37(23):E1464–1468.22872218
   PubMed Web of Science ®Google Scholar
• Ohtori S, Orita S, Yamauchi K, et al. More than 6 months of teriparatide treatment was more effective for bone union than shorter treatment following lumbar posterolateral fusion surgery. Asian Spine J. 2015;9(4):573–580.26240717
   PubMedGoogle Scholar
• Inoue G, Ueno M, Nakazawa T, et al. Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis. J Neurosurg Spine. 2014;21(3):425–431.24905394
   PubMed Web of Science ®Google Scholar
• Kaliya-Perumal AK, Lu ML, Luo CA, et al. Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery. Medicine. 2017;96(5):e5996.28151894
   PubMed Web of Science ®Google Scholar
• Park YS, Kim HS, Baek SW, Kong DY, Ryu JA. The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. Clin Orthop Surg. 2013;5(4):292–297.24340149
   PubMedGoogle Scholar